SLS: SELLAS Life Sciences Group, Inc. Stock

by  •  • Comments Off on SLS: SELLAS Life Sciences Group, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 116.28
Enterprise Value ($M) 102.40
Book Value ($M) 9.46
Book Value / Share 0.10
Price / Book 12.29
NCAV ($M) 6.36
NCAV / Share 0.07
Price / NCAV 18.28

Profitability (mra)
Return on Invested Capital (ROIC) -2.95
Return on Assets (ROA) -1.26
Return on Equity (ROE) -3.19

Liquidity (mrq)
Quick Ratio 1.72
Current Ratio 1.72

Balance Sheet (mrq) ($M)
Current Assets 16.33
Assets 19.43
Liabilities 9.97
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -31.51
Net Income -30.88
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -35.40
Cash from Investing 0.00
Cash from Financing 46.76

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-08 13G/A Highbridge Capital Management Llc 9.90 537.71

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 224,765 1,100,741 20.42
2025-04-16 248,865 1,475,239 16.87
2025-04-15 342,623 1,688,721 20.29
2025-04-14 125,239 738,381 16.96

(click for more detail)

Similar Companies
SILO – Silo Pharma, Inc. SLGL – Sol-Gel Technologies Ltd.
SLRX – Salarius Pharmaceuticals, Inc. SNDL – SNDL Inc.
SNGX – Soligenix, Inc.


Financial data and stock pages provided by
Fintel.io